Holkira Pak (generic name: ombitasvir/paritaprevir/ritonavir/dasabuvir) is being considered for BC PharmaCare coverage. The dates for input into this process are Wednesday, April 22nd, to Wednesday, May 20th—now.
If you are a BC resident and answer yes to any of the following questions for Holkira Pak, BC’s Health Care system wants to hear your input:
- Do you have hep C?
- Are you a caregiver to someone who has hep C?
- Does your patient group represent patients who have hep C AND have you registered with PharmaCare to give input? (Learn more about registering your organization).
Links to input questionnaire for Holkira Pak can be found at PharmaCare’s Your Voice.